Jim Weatherall, Head of Data Science and AI at AstraZeneca talks to Citi’s Adam Spielman about how AI will impact Biopharma, and how big pharma companies and small biotechs alike need to adapt.
My Account
Learn more about Global Insights at Citi
Subscribe
Sign up to receive our newsletter providing a roundup of recent content and updates on new reports.
Sign up to receive the latest news from Citi.
